Skip to content
Company Analysis

Koninklijke Philips N.V. NY Reg PHG

A comprehensive view of key metrics, scores, and financial health for Koninklijke Philips N.V. NY Reg

Overview of Koninklijke Philips N.V.

PHG NYQ
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Large Cap
Koninklijke Philips N.V. (PHG), is a Large Cap company, in the Medical Devices industry, last closed at $25.29, about 14.6% undervalued vs fair value, -10.3% 1Y return, placing in the top 25% of its sector.
Metrics P/E 29.1× Rev Growth -1.0% ROE 7.8% Gross Margin 45.2% Div Yield 1.31%
USD 25.29
-2.32%
(Delayed)
• Vol 90d: 28.2%
52-Week Range
Market Cap
$26.03B
Enterprise Value
$31.71B
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Excellent
Growth
Fair
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Excellent
Completeness: 100%
Confidence: 62%
Updated: Sep 12
Top Beats
No strong beats yet

Quick Facts

Website https://www.philips.com
HQ Amsterdam
Employees 61,085
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$25
$29
$33
Current: $25.29 +15% vs base

Engine Room Money Flow™

Large Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$17.8B
-1%%
Gross Profit
$8.1B
3.7%%
Operating Income (GAAP)
$1.4B
182.5%%
EBITDA
$2.6B
40.6%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
45.2%
Fair

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$328.0M
65.1% of Free Cash Flow

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
7
Active Leaks
1/7
Improving
1
High Impact
1
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Koninklijke Philips N.V. NY Reg's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
59
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Superior Capital Returns Capital return quality is top-tier (score 0.73). High ROIC indicates the business is reinvesting at attractive rates.
  • Strong Operating Margin vs Peers Operating margin level is strong vs peers (score 0.73). SG&A discipline is converting gross margin into operating profit efficiently.

Key risks

  • Below-Peer Gross Margins Gross margin quality lags peers (score 0.32). May indicate commodity-like product mix or distributor margin drag.
  • Declining FCF Margin FCF trend score is negative (score 0.22). Declining FCF margin warrants scrutiny of capital allocation discipline.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Developing
49
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 95% Coverage
Trade-Off Triangle Visualization A ternary plot showing PHG's balance between Growth (30.4%), Profitability (37.3%), and Safety (32.3%). Growth 30% Safety 32% Profitability 37%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

49th percentile vs peers
50
Key Signals
EPS Growth YoY 2.24 96p Rev Growth YoY -1.0% 31p Revenue CAGR 3Y 0.0% 32p TSR 8.3% 57p Asset Growth YoY -7.0% 32p
Strengths
  • EPS Growth YoY in top 20% of peers (2.24, 96th percentile)
  • Cash Flow to Debt Ratio in top 20% of peers (4.71, 94th percentile)
  • Superior capital returns - 2 return metrics above peer median
  • Consistently strong margins across 3 metrics
Risks

No significant risks identified for this axis.

Profitability

61th percentile vs peers
61
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

53th percentile vs peers
53
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Koninklijke Philips N.V. NY Reg.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$28.98
- - -
+14.6% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000